This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN J. GARTLAND, M.D.; WILLIAM R. MAC AUSLAND, Jr., M.D.

AMA Arch Surg. 1954;68(3):305-314.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN DISORDERS of the bones and joints, as in all other special fields of medicine, many primary conditions exist for which there is no definitive treatment, and also many troublesome complications are encountered that add to the difficulties of operation. During a clinical evaluation of hyaluronidase over the past three years, it became apparent that the enzyme might prove useful not only for rapid elimination of the extracellular fluid accumulations (edema, hematoma, hemarthrosis) that frequently complicate orthopedic conditions and delay operative treatment, but also for specific therapy or prophylaxis in certain surgical problems for which no satisfactory measures heretofore have been available.

The value of hyaluronidase as a useful adjunct in the treatment of fractures and other bone injuries has been stressed in an earlier report.¹ It seems apparent that hyaluronidase will find even greater usefulness through its ability to reduce soft-tissue swelling particularly as it relates to the . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA; BOSTON

From the New York Orthopaedic Hospital, and Columbia Presbyterian Medical Center, New York, and Jefferson Hospital, Philadelphia.

Footnotes
Read in part before the Forum on Fundamental Surgical Problems, 38th Clinical Congress of the American College of Surgeons, New York, Sept. 24, 1952.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?